-
October 04, 2012
Teva Pharmaceutical Industries Ltd (TEVA) recently announced a deal that will expand the company's central nervous ...
-
October 04, 2012
Advanced Care Scripts (ACS), a part of Omnicare Inc.'s (OCR) Specialty Care Group, has been recently included in the ...
-
September 27, 2012
After this morning's trading, the Nasdaq has increased 0.4%, the S&P 500 has moved up 0.3% and the Dow has remained ...
-
September 27, 2012
After the morning's trading, the Nasdaq has increased 0.4%, the S&P 500 has risen 0.3% and the Dow has moved little. ...
-
September 26, 2012
This morning's trading has marked a bad day for the market so far. The Nasdaq has slipped 1%; the S&P 500 has fallen ...
-
September 17, 2012
Medivation, Inc. (MDVN) and Astellas Pharma Inc. recently launched their prostate cancer treatment, Xtandi ...
-
September 17, 2012
The market is down this morning. The Nasdaq is down 0.2%; the S&P 500 is trading down 0.2%; and the Dow has slipped ...
-
September 17, 2012
The market is having a bad day so far: the Nasdaq has slipped 0.2%; the S&P 500 has declined 0.2%; and the Dow is ...
-
September 12, 2012
The morning has been good for the market. The Nasdaq has moved up 0.1%; the S&P 500 has risen 0.3%; and the Dow has ...
-
September 04, 2012
Medivation, Inc. (MDVN) and partner, Astellas Pharma Inc., received a major boost with the US Food and Drug ...
-
September 04, 2012
This morning has been rocky for the market. The Nasdaq has decreased 0.8%; the S&P 500 has slipped 0.5%; and the Dow ...
-
September 04, 2012
The market is currently down, with the Nasdaq slipping 0.8%, the S&P 500 down 0.6% and the Dow declining 0.8%. The ...
-
August 20, 2012
The market is having a bad day so far: the Nasdaq has slipped 0.2%; the S&P 500 is down 0.3%; and the Dow is trading ...
-
August 13, 2012
Medivation Inc. (MDVN) reported second quarter loss of 15 cents per share, wider than the Zacks Consensus Estimate ...
-
August 08, 2012
The week ahead for healthcare stocks.
-
August 07, 2012
Medivation, Inc. (MDVN) and Astellas Pharma Inc. recently announced that the US Food and Drug Administration (FDA) ...
-
August 07, 2012
Pfizer, Inc. (PFE) recently announced disappointing late-stage results on intravenous (IV) bapineuzumab. ...
-
July 31, 2012
Dendreon Corporation (DNDN) reported second-quarter 2012 loss (including stock-based compensation expense but ...
-
July 30, 2012
The market is having a bad day so far. The Nasdaq has fallen 0.2%; the S&P 500 has declined 0.1%; and the Dow is ...
-
July 27, 2012
Medivation Inc. (MDVN) and its partner Astellas Pharma Inc. recently reported that the New Drug Application (NDA) ...
